2006 Fiscal Year Final Research Report Summary
Development of inhibitor against intestinal bacterium infection by using artificial mucin
Project/Area Number |
16580072
|
Research Category |
Grant-in-Aid for Scientific Research (C)
|
Allocation Type | Single-year Grants |
Section | 一般 |
Research Field |
Applied biochemistry
|
Research Institution | Shizuoka University |
Principal Investigator |
MURATA Takeomi Shizuoka University, Faculty of Agriculture, Associate, 農学部, 助教授 (30273171)
|
Project Period (FY) |
2004 – 2006
|
Keywords | mucin / GlcNAc / glycosyltransferase / Helicobacter pylori / horse / serum |
Research Abstract |
Gastrointestinal mucins having GlcNAcα1,4Galβ-R are known to play protective roles against Helicobacter pylori infection. Our research is to develop a synthetic root of artificial mucin with a polyglutamic acid backbone carrying multivalent glycan, which functions as an inhibitor against H pylori infection. 1. Artificial. mucin Mucins, highly glycosylated proteins that form the major component of mucosa, are known to play a physiological role as barrier to biomolecules. Highly water-soluble, artificial glycopolypeptides with a polyglutamic acid backbone carrying multivalent GlcNAcα1,4Galβ-units, termed 'artificial mucins' have been chemoenzymatically synthesized as potential polymeric inhibitors of infection by H. pylori. In the case, α1,4-N-acetylglucosaminyltransferase (α4GnT) in horse serum, which was obtained by screening of the enzyme activity in various kinds of serums, was used as a tool for synthesizing an epitope of GlcNAc□, 4Gal□-R glycoside. 2. Purification of α4GnT from horse serum An α4GnT from horse serum was purified 5,300 fold by fractionation with ammonium sulfate, foolowed by sequential chromatographies by CM-Sepharose, Concanavalin A-agarose, Superdex 200 p.g, and UDP-hexanolamine agarose. The purified enzyme was highly specific for an acceptor substrate Galβ-3GalNAcαpNP having core 1 strucrure, on G1cNAc transfer from UDP-G1cNAc donor
|
Research Products
(11 results)